Two studies have noted that immunophenotypically-confirmed ETP-ALL cases were enriched in the LYL1/LMO2 subtype compared with all other subtypes (37% [15] and 44% [14]). The gene discussed is LMO2; the disease is acute lymphoblastic leukemia.